» Articles » PMID: 40076965

Impact of Tick-Borne Infection on Compact Human Brain Endothelial Barrier

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Mar 13
PMID 40076965
Authors
Affiliations
Soon will be listed here.
Abstract

Tick-borne encephalitis remains a significant burden on human health in the endemic areas in Central Europe and Eastern Asia. The causative agent, tick-borne encephalitis virus (TBEV), is a neurotropic virus belonging to the genus of . After TBEV enters the central nervous system (CNS), it mainly targets neurons, causing encephalitis and leading to life-long disabilities, coma and, in rare cases, death. The neuroinvasive mechanisms of orthoflaviviruses are poorly understood. Here we investigate the mechanism of TBEV neuroinvasion, hypothesizing that TBEV influences blood-brain barrier (BBB) properties and uses transcellular routes to cross the endothelial barrier and enter the CNS. To test this hypothesis, we employed an in vitro transwell system consisting of endothelial cell monolayers cultured on insert membranes and studied the barrier properties following inoculation to tick-borne orthoflaviviruses. It was shown that TBEV and closely related but naturally attenuated Langat virus (LGTV) crossed the intact endothelial cell monolayer without altering its barrier properties. Interestingly, transendothelial migration of TBEV was significantly affected when two cellular surface antigens, the laminin-binding protein and vimentin, were blocked with specific antibodies. Taken together, these results indicate that orthoflaviviruses use non-destructive transcellular routes through endothelial cells to establish infection within the CNS.

References
1.
Petry M, Palus M, Leitzen E, Mitterreiter J, Huang B, Kroger A . Immunity to TBEV Related Flaviviruses with Reduced Pathogenicity Protects Mice from Disease but Not from TBEV Entry into the CNS. Vaccines (Basel). 2021; 9(3). PMC: 7996866. DOI: 10.3390/vaccines9030196. View

2.
Kaiser R . The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain. 1999; 122 ( Pt 11):2067-78. DOI: 10.1093/brain/122.11.2067. View

3.
Pradier S, Lecollinet S, Leblond A . West Nile virus epidemiology and factors triggering change in its distribution in Europe. Rev Sci Tech. 2013; 31(3):829-44. DOI: 10.20506/rst.31.3.2167. View

4.
Ruzek D, Avsic Zupanc T, Borde J, Chrdle A, Eyer L, Karganova G . Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 2019; 164:23-51. DOI: 10.1016/j.antiviral.2019.01.014. View

5.
Zhu Z, Mesci P, Bernatchez J, Gimple R, Wang X, Schafer S . Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αβ Axis. Cell Stem Cell. 2020; 26(2):187-204.e10. PMC: 9628766. DOI: 10.1016/j.stem.2019.11.016. View